| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 30 |
| 1 | ADALIMUMAB | 20 |
| 2 | CLADRIBINE | 19 |
| 3 | INFLIXIMAB | 15 |
| 4 | ETANERCEPT | 14 |
| 5 | METHOTREXATE | 14 |
| 6 | METHOTREXATE SODIUM | 14 |
| 7 | PREDNISONE | 14 |
| 8 | CYCLOSPORINE | 11 |
| 9 | VEMURAFENIB | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MAGESIUM CITRATE | 1 | 0.0109 |
| 1 | PENTOSTATIN | 9 | 0.0086 |
| 2 | METEX | 1 | 0.0026 |
| 3 | CLADRIBINE | 19 | 0.0019 |
| 4 | RITUXIMAB-ABBS | 9 | 0.0018 |
| 5 | PEMIGATINIB | 1 | 0.0012 |
| 6 | VEMURAFENIB | 10 | 0.0008 |
| 7 | TERBINAFINE TABLETS 250 MG | 1 | 0.0008 |
| 8 | ANTIHEMOPHILIC FACTOR HUMAN | 1 | 0.0007 |
| 9 | TREOSULFAN | 2 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Allylamine Antifungal [EPC] | 4 | 0.0006 |
| 1 | Purine Antimetabolite [EPC] | 24 | 0.0002 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 2 | 0.0002 |
| 3 | Parenteral Iron Replacement [EPC] | 2 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 40 | 0.0001 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 11 | 0.0001 |
| 7 | Aluminum Complex [EPC] | 2 | 0.0001 |
| 8 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0001 |